About: Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Sector: Healthcare
Industry: Biotechnology
Latest price: $36.64 (-4.06%)
NBTXNASDAQNanobiotix
Nanobiotix share price
NBTX price activity
Last Price
$36.640
Change (24hr)
-1.55 USD (-4.06%)
Volume
104.81K
Volume (4w avg)
-
Open
$35.45
Day Range
$35.45 - $36.72
Previous Close
$38.19
Last Trade
09 Sep, 8:05 pm GMT+0
Delayed
09 Sep, 8:05 pm GMT+0
NBTX price performance
Delayed
09 Sep, 8:05 pm GMT+0
NBTX Market Signals